emtricitabine and tenofovir disoproxil fumarate
Drug Details
- Generic Name
- emtricitabine and tenofovir disoproxil fumarate
- Brand Names
- Truvada
- Application Number
- NDA021752
- Sponsor
- Patheon Inc.
- NDC Codes
- 15
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE Efavirenz, Emtricitabine and Tenofovir disoproxil fumarate tablet is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablet is a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )